Nagoya University Hospital - Transfusion Medicine
Nagoya, Aichi, Japan
Hospital in Nagoya
〒466-8560 Aichi, Nagoya, Showa Ward, Tsurumaicho, ６５
About Nagoya University Hospital - Transfusion Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Nagoya University Hospital - Transfusion Medicine
During the past decade, Nagoya University Hospital - Transfusion Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-05-01
2012-04-01
Completed
742
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
2008-10-17
2020-12-07
Completed
550
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
2009-12-01
2014-10-01
Completed
1,156
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Nagoya University Hospital - Transfusion Medicine
According to Clinical.Site data, the most researched conditions in "Nagoya University Hospital - Transfusion Medicine" are
"Hemophilia A" (4 trials) and "Hemophilia B" (3 trials). Many other conditions were trialed in "Nagoya University Hospital - Transfusion Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Nagoya University Hospital - Transfusion Medicine
Most popular intervention types in "Nagoya University Hospital - Transfusion Medicine" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "PF-06741086" (2 trials), "PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy" (1 trials), "Standard of Care FIX Replacement therapy" (1 trials) and "Standard of Care FVIII Replacement therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nagoya University Hospital - Transfusion Medicine
The vast majority of trials in "Nagoya University Hospital - Transfusion Medicine" are
4 trials for "Male" genders.
Clinical Trials Status at Nagoya University Hospital - Transfusion Medicine
Currently, there are NaN active trials in "Nagoya University Hospital - Transfusion Medicine".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Nagoya University Hospital - Transfusion Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nagoya University Hospital - Transfusion Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".